Prevalencia del anticuerpo anti receptor de fosfolipasa A2 sérico e histológico en pacientes con nefropatía membranosa en un Centro Universitario / Phospholipase A2 receptor antigen antibodies in serum and renal biopsies of patients with membranous nephropathy
Rev. méd. Chile
;
149(1): 7-12, ene. 2021. tab, ilus
Article
Dans Espagnol
| LILACS
| ID: biblio-1389340
ABSTRACT
BACKGROUND:
The discovery of the phospholipase A2 receptor antigen and its highly specific autoantibody (anti-PLA2R Ab) was useful for the diagnosis and follow-up of patients with membranous nephropathy (MN). Thus, some international guidelines recommend not performing renal biopsy in patients with positive serum anti-PLA2R Ab.Aim:
To evaluate the prevalence of anti-PLA2R Ab in serum and renal tissue samples from Chilean patients with primary MN. MATERIAL ANDMETHODS:
Twenty-eight patients aged 50 ± 14 years (20 males) with biopsy-proven primary MN plus a negative workup for secondary causes were included. Measurements of serum and renal histologic anti-PLA2R Ab were performed. The relationship between the findings of serum and tissue anti-PLA2R Ab was evaluated.RESULTS:
Fifteen patients (54 %) had anti-PLA2R Ab presence in serum and 19 patients (68%) had positive anti-PLA2R Ab in the renal biopsy. All patients with positive serum anti-PLA2R Ab had positive antibodies on immunohistochemistry.Conclusions:
Serum anti-PLA2R Ab is potentially useful in the diagnosis of patients with suspected primary MN in Chilean population.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Glomérulonéphrite extra-membraneuse
/
Récepteurs à la phospholipase A2
Type d'étude:
Guide de pratique
/
Étude de prévalence
/
Facteurs de risque
/
Étude de dépistage
Limites du sujet:
Femelle
/
Humains
/
Mâle
Pays comme sujet:
Amérique du Sud
/
Chili
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2021
Type:
Article
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Hospital Clínico Universidad de Chile/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS